tiprankstipranks
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market
ASND
Ascendis Pharma
RESEARCH TOOLSreports
Want to see ASND full AI Analyst Report?

Ascendis Pharma (ASND) Ratios

755 Followers

Ascendis Pharma Ratios

ASND's free cash flow for Q2 2026 was €0.91. For the 2026 fiscal year, ASND's free cash flow was decreased by € and operating cash flow was €0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.99 1.04 1.17 0.95 1.29
Quick Ratio
 2.32 0.76 0.84 0.67 1.11
Cash Ratio
 1.75 0.58 0.62 0.53 0.62
Solvency Ratio
 0.91 -0.14 -0.28 -0.48 -0.68
Operating Cash Flow Ratio
 0.76 0.05 -0.34 -0.63 -0.69
Short-Term Operating Cash Flow Coverage
 5.37 0.11 -0.62 -1.11 -1.20
Net Current Asset Value
€ 540.66M€ -356.25M€ -224.34M€ -268.56M€ 97.08M
Leverage Ratios
Debt-to-Assets Ratio
 0.20 0.67 0.73 0.90 0.57
Debt-to-Equity Ratio
 0.31 -5.35 -8.10 -5.10 2.35
Debt-to-Capital Ratio
 0.24 1.23 1.14 1.24 0.70
Long-Term Debt-to-Capital Ratio
 0.21 1.73 1.41 2.88 0.27
Financial Leverage Ratio
 1.59 -8.00 -11.16 -5.67 4.14
Debt Service Coverage Ratio
 3.20 -0.22 -0.53 -0.90 -1.20
Interest Coverage Ratio
 0.67 -1.69 -4.26 -10.34 -18.31
Debt to Market Cap
 0.03 0.08 0.11 0.10 0.08
Interest Debt Per Share
 9.54 15.66 15.93 13.98 11.56
Net Debt to EBITDA
 -4.63 -2.33 -1.02 -0.85 -0.33
Profitability Margins
Gross Profit Margin
90.19%85.08%87.83%83.36%76.28%
EBIT Margin
5.73%-18.33%-84.63%-161.25%-1069.17%
EBITDA Margin
7.41%-15.87%-79.76%-154.16%-1034.07%
Operating Profit Margin
10.38%-18.92%-76.66%-170.79%-1097.85%
Pretax Profit Margin
9.59%-29.53%-102.64%-177.77%-1129.12%
Net Profit Margin
71.69%-31.67%-103.97%-180.51%-1139.63%
Continuous Operations Profit Margin
71.69%-31.67%-103.97%-180.51%-1139.63%
Net Income Per EBT
747.57%107.23%101.30%101.54%100.93%
EBT Per EBIT
92.38%156.05%133.89%104.08%102.85%
Return on Assets (ROA)
33.08%-16.82%-32.05%-58.32%-53.52%
Return on Equity (ROE)
190.44%134.58%357.68%330.44%-221.45%
Return on Capital Employed (ROCE)
6.01%-56.16%-102.63%-511.40%-150.64%
Return on Invested Capital (ROIC)
5.80%-18.19%-36.53%-86.85%-70.25%
Return on Tangible Assets
33.13%-16.87%-32.16%-58.63%-53.76%
Earnings Yield
5.17%-1.99%-4.91%-7.51%-9.12%
Efficiency Ratios
Receivables Turnover
 4.71 4.39 2.19 7.43 4.30
Payables Turnover
 1.00 1.14 0.46 0.47 0.12
Inventory Turnover
 0.33 0.34 0.15 0.21 0.09
Fixed Asset Turnover
 7.77 4.72 3.68 2.41 0.40
Asset Turnover
 0.46 0.53 0.31 0.32 0.05
Working Capital Turnover Ratio
 2.29 7.18 6.10 3.09 0.11
Cash Conversion Cycle
 806.22 828.84 1.81K 989.36 976.35
Days of Sales Outstanding
 77.55 83.18 166.90 49.09 84.95
Days of Inventory Outstanding
 1.10K 1.07K 2.44K 1.72K 3.93K
Days of Payables Outstanding
 366.42 320.56 794.97 777.49 3.04K
Operating Cycle
 1.17K 1.15K 2.60K 1.77K 4.01K
Cash Flow Ratios
Operating Cash Flow Per Share
 5.46 0.85 -5.29 -8.30 -8.84
Free Cash Flow Per Share
 5.24 0.72 -5.31 -8.35 -9.10
CapEx Per Share
 0.22 0.13 0.02 0.04 0.26
Free Cash Flow to Operating Cash Flow
 0.96 0.84 1.00 1.01 1.03
Dividend Paid and CapEx Coverage Ratio
 24.35 6.35 -214.57 -191.38 -34.21
Capital Expenditure Coverage Ratio
 24.35 6.35 -214.57 -191.38 -34.21
Operating Cash Flow Coverage Ratio
 0.78 0.06 -0.36 -0.63 -0.80
Operating Cash Flow to Sales Ratio
 0.33 0.07 -0.84 -1.75 -9.69
Free Cash Flow Yield
2.39%0.40%-4.00%-7.32%-7.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.77 -50.13 -20.36 -13.32 -10.97
Price-to-Sales (P/S) Ratio
 13.38 15.90 21.17 24.05 124.97
Price-to-Book (P/B) Ratio
 10.18 -67.58 -72.81 -44.02 24.28
Price-to-Free Cash Flow (P/FCF) Ratio
 41.87 252.17 -25.02 -13.65 -12.54
Price-to-Operating Cash Flow Ratio
 41.60 212.47 -25.14 -13.72 -12.90
Price-to-Earnings Growth (PEG) Ratio
 0.03 1.13 0.86 0.75 -0.23
Price-to-Fair Value
 10.18 -67.58 -72.81 -44.02 24.28
Enterprise Value Multiple
 175.93 -102.51 -27.56 -16.45 -12.41
Enterprise Value
 13.74B 11.26B 7.99B 6.76B 6.57B
EV to EBITDA
 175.93 -102.51 -27.56 -16.45 -12.41
EV to Sales
 13.04 16.27 21.98 25.36 128.35
EV to Free Cash Flow
 40.80 258.03 -25.99 -14.40 -12.87
EV to Operating Cash Flow
 39.12 217.41 -26.11 -14.47 -13.25
Tangible Book Value Per Share
 22.26 -2.75 -1.90 -2.67 4.61
Shareholders’ Equity Per Share
 22.32 -2.69 -1.83 -2.59 4.70
Tax and Other Ratios
Effective Tax Rate
 -6.48 -0.07 -0.01 -0.02 >-0.01
Revenue Per Share
 16.39 11.41 6.28 4.74 0.91
Net Income Per Share
 11.75 -3.61 -6.53 -8.55 -10.40
Tax Burden
 7.48 1.07 1.01 1.02 1.01
Interest Burden
 1.67 1.61 1.21 1.10 1.06
Research & Development to Revenue
 0.26 0.41 0.84 1.55 7.42
SG&A to Revenue
 0.54 0.63 0.78 0.97 4.22
Stock-Based Compensation to Revenue
 0.03 0.00 0.26 0.25 1.25
Income Quality
 0.46 -0.24 0.81 0.97 0.85
Currency in EUR